Ngā hua rapu - Luiza Abdo
-
1
-
2
Piggybac transposon-based production of anti-HER2 CAR T cell
I whakaputaina 2022Whiwhi kuputuhi katoa Whiwhi kuputuhi katoaArtigo -
3
Cost-Effective Strategies for CAR-T Cell Therapy Manufacturing
I whakaputaina 2025Whiwhi kuputuhi katoaRevisão -
4
-
5
-
6
-
7
Development of CAR T therapy for ALL-B using the point of care approach
I whakaputaina 2019Whiwhi kuputuhi katoa Whiwhi kuputuhi katoaArtigo -
8
-
9
Anti-HER2 CAR-T cells evaluation in a ovarian tumor preclinical model
I whakaputaina 2023Whiwhi kuputuhi katoa Whiwhi kuputuhi katoaArtigo -
10
-
11
Generation of 19bbz CAR-T cells in tcr knockout T-cells
I whakaputaina 2023Whiwhi kuputuhi katoa Whiwhi kuputuhi katoaArtigo -
12
-
13
Development of CAR-T Cell Therapy for B-ALL Using a Point-of-Care Approach
I whakaputaina 2019Whiwhi kuputuhi katoa Whiwhi kuputuhi katoaPré-impressão -
14
Development of CAR-T cell therapy for B-ALL using a point-of-care approach
I whakaputaina 2020Whiwhi kuputuhi katoa Whiwhi kuputuhi katoaArtigo -
15
-
16
-
17
-
18
-
19